共 15 条
[1]
Nilsson G.H., Bjorholt I., Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: A retrospective study on electronic patient records, BMC Clinical Pharmacology, 4, (2004)
[2]
Wandell P.E., Anticoagulant patients in Swedish primary health care, A comparison 5 years apart, Scand J Prim Health Care, 16, pp. 183-187, (1998)
[3]
Geerts W.H., Pineo G.F., Heit J.A., Bergqvist, Lassen M.R., Colwell C.W., Ray J.G., Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, pp. 338-400, (2004)
[4]
Hart R., Sherman D., Easton J., Cairns J., Prevention of stroke in patients with nonvalvular atrial fibrillation, Neurology, 51, 3, pp. 674-681, (1998)
[5]
Hart R.G., Atrial fibrillation and stroke prevention, N Engl J Med, 349, 11, pp. 1015-1016, (2003)
[6]
Verheugt F.W., Warfarin for ischemic heart disease, Cardiol Rev, 9, 6, pp. 325-328, (2001)
[7]
Evans C., The use of consensus methods and expert panels in pharmacoeconomic studies. - Practical applications and methodological shortcomings, Pharmacoeconomics, 12, 2 PART 1, pp. 121-129, (1997)
[8]
Jairath N., Weinstein J., The Delphi methodology (Part One): A useful administrative approach, Can J Nurs Adm, 7, 3, pp. 29-42, (1994)
[9]
Jairath N., Weinstein J., The Delphi methodology (Part Two): A useful administrative approach, Can J Nurs Adm, 7, 4, pp. 7-20, (1994)
[10]
Jones J., Hunter D., Consensus methods for medical and health services research, BMJ, 311, (1995)